Bio Protocol has introduced OpenLabs, a platform that connects scientific researchers and AI agents with a USDC-based revenue model to fund decentralized science projects. This approach replaces traditional grant funding with stablecoin payments, offering predictable budgets and ongoing revenue streams tied to project outputs. OpenLabs also integrates AI agents to assist in research tasks, enhancing collaboration and efficiency. The platform aims to bridge the gap between academic research and blockchain infrastructure, though adoption depends on demonstrating tangible scientific results.
Bitcoin started July strong, trading above $63,000 after a tough first half of 2026, with a 6.09% weekly gain despite being down nearly 28% year-to-date. The rebound is driven by large holders aggressively buying the dip, while institutional demand w...
XRP's market capitalization has approached that of USDC, narrowing the gap from $75.66 billion vs. $71.65 billion in early June to $72.93 billion vs. $70.81 billion by early July 2026. Despite brief intraday data suggesting XRP might have overtaken U...
Revolut will stop supporting Tether's USDT stablecoin by August 31, 2026, to comply with the EU's MiCA regulations, which require stablecoins to have EU approval. Users can no longer buy USDT after July 6 and deposits will be disabled after July 30. ...
Revolut will stop supporting the stablecoin USDT on August 31, 2026, due to the European Union's new Markets in Crypto-Assets (MiCA) regulations. Users can buy USDT until July 6 and deposit until July 30, with the option to sell or transfer USDT unti...
The U.S. Senate is set to release the Bitcoin Clarity Act soon, aiming to clarify crypto regulations and reduce legal uncertainty for digital asset firms. This move coincides with renewed inflows into U.S.-listed spot Bitcoin and Ethereum ETFs, signa...
